学术探索
学术期刊
新闻热点
数据分析
智能评审

Plasma sRAGE is independently associated with urinary albumin excretion in type 2 diabetes

被引：37
作者：
Humpert, PM [1 ]
Kopf, S [1 ]
Djuric, Z [1 ]
Wendt, T [1 ]
Morcos, M [1 ]
Nawroth, PP [1 ]
Bierhaus, A [1 ]
机构：
[1] Univ Klinikum Heidelberg, Med Klin 1, D-69120 Heidelberg, Germany
来源：
DIABETES CARE | 2006年 / 29卷 / 05期
关键词：
D O I：
10.2337/dc05-2478
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1111 / 1113
页数：3
相关论文
共 17 条
  • [1] ABEL M, 1995, NEPHROL DIAL TRANSPL, V10, P1662
  • [2] Understanding RAGE, the receptor for advanced glycation end products
    Bierhaus, A
    Humpert, PM
    Morcos, M
    Wendt, T
    Chavakis, T
    Arnold, B
    Stern, DM
    Nawroth, PP
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (11): : 876 - 886
  • [3] Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily
    Bierhaus, A
    Haslbeck, KM
    Humpert, PM
    Liliensiek, B
    Dehmer, T
    Morcos, M
    Sayed, AAR
    Andrassy, M
    Schiekofer, S
    Schneider, JG
    Schulz, JB
    Heuss, D
    Neundörfer, B
    Dierl, S
    Huber, J
    Tritschler, H
    Schmidt, AM
    Schwaninger, M
    Haering, HU
    Schleicher, E
    Kasper, M
    Stern, DM
    Arnold, B
    Nawroth, PP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (12) : 1741 - 1751
  • [4] RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice
    Bucciarelli, LG
    Wendt, T
    Qu, W
    Lu, Y
    Lalla, E
    Rong, LL
    Goova, MT
    Moser, B
    Kislinger, T
    Lee, DC
    Kashyap, Y
    Stern, DM
    Schmidt, AM
    [J]. CIRCULATION, 2002, 106 (22) : 2827 - 2835
  • [5] Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes
    Challier, M
    Jacqueminet, S
    Benabdesselam, O
    Grimaldi, A
    Beaudeux, JL
    [J]. CLINICAL CHEMISTRY, 2005, 51 (09) : 1749 - 1750
  • [6] Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice
    Flyvbjerg, A
    Denner, L
    Schrijvers, BF
    Tilton, RG
    Mogensen, TH
    Paludan, SR
    Rasch, R
    [J]. DIABETES, 2004, 53 (01) : 166 - 172
  • [7] Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy
    Forbes, JM
    Thorpe, SR
    Thallas-Bonke, V
    Pete, J
    Thomas, MC
    Deemer, ER
    Bassal, S
    El-Osta, A
    Long, DM
    Panagiotopoulos, S
    Jerums, G
    Osicka, TM
    Cooper, ME
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (08): : 2363 - 2372
  • [8] Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients - Its possible association with diabetic vascular complications
    Katakami, N
    Matsuhisa, M
    Kaneto, H
    Matsuoka, TA
    Sakamoto, K
    Nakatani, Y
    Ohtoshi, K
    Hayaishi-Okano, R
    Kosugi, K
    Hori, M
    Yamasaki, Y
    [J]. DIABETES CARE, 2005, 28 (11) : 2716 - 2721
  • [9] Nε-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression
    Kislinger, T
    Fu, CF
    Huber, B
    Qu, W
    Taguchi, A
    Yan, SD
    Hofmann, M
    Yan, SF
    Pischetsrieder, M
    Stern, D
    Schmidt, AM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (44) : 31740 - 31749
  • [10] Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis
    Koyama, H
    Shoji, T
    Yokoyama, H
    Motoyama, K
    Mori, K
    Fukumoto, S
    Emoto, M
    Shoji, T
    Tamei, H
    Matsuki, H
    Sakurai, S
    Yamamoto, Y
    Yonekura, H
    Watanabe, T
    Yamamoto, H
    Nishizawa, Y
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (12) : 2587 - 2593
12